KR102550993B1 - Health functional food for improving bronchial function or enhancing immune function - Google Patents
Health functional food for improving bronchial function or enhancing immune function Download PDFInfo
- Publication number
- KR102550993B1 KR102550993B1 KR1020220130190A KR20220130190A KR102550993B1 KR 102550993 B1 KR102550993 B1 KR 102550993B1 KR 1020220130190 A KR1020220130190 A KR 1020220130190A KR 20220130190 A KR20220130190 A KR 20220130190A KR 102550993 B1 KR102550993 B1 KR 102550993B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- functional food
- health functional
- function
- quince
- Prior art date
Links
- 230000036541 health Effects 0.000 title claims abstract description 38
- 235000013376 functional food Nutrition 0.000 title claims abstract description 33
- 230000036737 immune function Effects 0.000 title claims abstract description 8
- 230000002708 enhancing effect Effects 0.000 title abstract description 6
- 241000332371 Abutilon x hybridum Species 0.000 claims abstract description 17
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 16
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 16
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 16
- 229940010454 licorice Drugs 0.000 claims abstract description 16
- 235000017788 Cydonia oblonga Nutrition 0.000 claims abstract description 15
- 235000013399 edible fruits Nutrition 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 12
- 240000006079 Schisandra chinensis Species 0.000 claims description 10
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 10
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 9
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 9
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 9
- 244000273928 Zingiber officinale Species 0.000 claims description 9
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 9
- 235000008397 ginger Nutrition 0.000 claims description 9
- 230000006872 improvement Effects 0.000 claims description 8
- 235000010469 Glycine max Nutrition 0.000 claims description 7
- 244000068988 Glycine max Species 0.000 claims description 7
- 241001106462 Ulmus Species 0.000 claims description 7
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 claims description 7
- 240000008397 Ganoderma lucidum Species 0.000 claims description 6
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 6
- 244000299790 Rheum rhabarbarum Species 0.000 claims description 3
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 3
- 235000019714 Triticale Nutrition 0.000 claims description 2
- 241000228158 x Triticosecale Species 0.000 claims description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 claims 2
- 244000126002 Ziziphus vulgaris Species 0.000 claims 2
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 12
- 206010011224 Cough Diseases 0.000 abstract description 7
- 208000023504 respiratory system disease Diseases 0.000 abstract description 7
- 208000006673 asthma Diseases 0.000 abstract description 3
- 206010006451 bronchitis Diseases 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 208000014181 Bronchial disease Diseases 0.000 abstract description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 2
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- 230000001788 irregular Effects 0.000 abstract description 2
- 208000026435 phlegm Diseases 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 208000029462 Immunodeficiency disease Diseases 0.000 abstract 1
- 240000008866 Ziziphus nummularia Species 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 241001247821 Ziziphus Species 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 10
- 239000000428 dust Substances 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 7
- 239000013543 active substance Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000013373 food additive Nutrition 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- 206010039083 rhinitis Diseases 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 102000003984 Aryl Hydrocarbon Receptors Human genes 0.000 description 3
- 108090000448 Aryl Hydrocarbon Receptors Proteins 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 244000246386 Mentha pulegium Species 0.000 description 3
- 235000016257 Mentha pulegium Nutrition 0.000 description 3
- 235000004357 Mentha x piperita Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000007884 disintegrant Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 235000001050 hortel pimenta Nutrition 0.000 description 3
- 239000003018 immunosuppressive agent Substances 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000005078 Chaenomeles speciosa Nutrition 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000251905 Pseudocydonia sinensis Species 0.000 description 2
- 235000017831 Pseudocydonia sinensis Nutrition 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 244000013123 dwarf bean Species 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 229960003444 immunosuppressant agent Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000013618 particulate matter Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 230000005195 poor health Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 230000001932 seasonal effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241001532026 Liriope muscari Species 0.000 description 1
- BXTNNJIQILYHJB-GFCCVEGCSA-N Methylophiopogonanone A Natural products C1=C2OCOC2=CC(C[C@@H]2COC3=C(C)C(O)=C(C(=C3C2=O)O)C)=C1 BXTNNJIQILYHJB-GFCCVEGCSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- NEAPKZHDYMQZCB-UHFFFAOYSA-N N-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]ethyl]-2-oxo-3H-1,3-benzoxazole-6-carboxamide Chemical group C1CN(CCN1CCNC(=O)C2=CC3=C(C=C2)NC(=O)O3)C4=CN=C(N=C4)NC5CC6=CC=CC=C6C5 NEAPKZHDYMQZCB-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical group O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- QBRLTNYECODTFP-NSHDSACASA-N Ophiopogonanone A Natural products O=C1[C@@H](Cc2cc3OCOc3cc2)COc2c1c(O)c(C)c(O)c2 QBRLTNYECODTFP-NSHDSACASA-N 0.000 description 1
- QBRLTNYECODTFP-UHFFFAOYSA-N Ophiopogonanone A Chemical compound C1=C2OCOC2=CC(CC2COC3=CC(O)=C(C(=C3C2=O)O)C)=C1 QBRLTNYECODTFP-UHFFFAOYSA-N 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 241000245165 Rhododendron ponticum Species 0.000 description 1
- PBWOIPCULUXTNY-UHFFFAOYSA-N Sitosterylacetat Natural products C1C=C2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 PBWOIPCULUXTNY-UHFFFAOYSA-N 0.000 description 1
- 244000046109 Sorghum vulgare var. nervosum Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 238000012754 cardiac puncture Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- AUTZLTCWRDPAPV-UHFFFAOYSA-N methylophiopogonone A Chemical compound C1=C2OCOC2=CC(CC2=COC3=C(C)C(O)=C(C(=C3C2=O)O)C)=C1 AUTZLTCWRDPAPV-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000019462 natural additive Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000000689 peptic esophagitis Diseases 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920005547 polycyclic aromatic hydrocarbon Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- XTQHKBHJIVJGKJ-UHFFFAOYSA-N sulfur monoxide Chemical class S=O XTQHKBHJIVJGKJ-UHFFFAOYSA-N 0.000 description 1
- 229910052815 sulfur oxide Inorganic materials 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/314—Foods, ingredients or supplements having a functional effect on health having an effect on lung or respiratory system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Abstract
본 발명의 건강기능식품은 모과, 감초, 대추 및 도라지를 필수적 구성요소로 포함하고 있어, 기관지 기능의 개선 또는 면역기능의 증강 효과가 매우 우수하다. 본 발명의 건강기능식품 내 포함된 유효물질들이 시너지 효과를 발휘하여 기침, 가래, 천식, 기관지염 등의 기관지 질환과, 각종 면역의 결핍 등으로부터 발생하는 질환과 같이, 환경오염과 불규칙한 생활 방식, 스트레스로 인한 각종 호흡기 질환과 면역 결핍성 질환의 위험에 노출되어 있는 현대인들에게 유용하게 이용될 수 있을 것으로 기대할 수 있다.The health functional food of the present invention contains quince, licorice, jujube and bellflower as essential components, and thus has a very excellent effect of improving bronchial function or enhancing immune function. Effective substances contained in the health functional food of the present invention exert a synergistic effect to prevent bronchial diseases such as cough, phlegm, asthma, and bronchitis, as well as diseases caused by various immune deficiencies, such as environmental pollution, irregular lifestyle, and stress. It can be expected to be useful for modern people who are exposed to the risk of various respiratory diseases and immunodeficiency diseases due to
Description
본 발명은 기관지 기능의 개선 또는 면역기능의 증강을 위한 건강기능식품에 관련된 것이다.The present invention relates to a health functional food for improving bronchial function or enhancing immune function.
미세먼지(Particulate Matter, PM)란 공기 중 장기간 떠다니는 미세한 먼지를 말하며, 입경 2.5 μm 이하의 크기는 초미세먼지로 분류된다. 지난 수십 년간 우리나라의 급격한 산업화 및 공업화로 인해 환경이 지속적으로 악화되어 왔으며, 최근 중국의 높은 석탄 의존도와 급격한 경제 성장과 더불어 스모그 현상이 지속적으로 증가하여 미세먼지의 발생이 빈번해지고 있다. 황산화물, 질소산화물, 납 등의 유해물질들이 포함된 미세먼지는 호흡기 및 피부를 통해 인체 내에 침투할 수 있으며, 폐기능 감소, 천식 악화, 만성기관지염 발생 등 호흡기계 관련 질환을 야기하며, 심근경색, 협심증, 부정맥 등 심혈관계 관련 질환의 발생을 증가시키는 것으로 알려져 있다(김오식 외, 2009, ReSEAT 분석보고서).Particulate Matter (PM) refers to fine dust floating in the air for a long time, and particles with a diameter of 2.5 μm or less are classified as ultrafine dust. Due to rapid industrialization and industrialization in Korea over the past decades, the environment has been continuously deteriorating. Recently, China's high dependence on coal and rapid economic growth have continuously increased smog, resulting in frequent occurrence of fine dust. Fine dust containing harmful substances such as sulfur oxides, nitrogen oxides, and lead can penetrate into the human body through the respiratory tract and skin, causing respiratory system-related diseases such as decreased lung function, exacerbation of asthma, and occurrence of chronic bronchitis, and myocardial infarction. It is known to increase the incidence of cardiovascular-related diseases such as angina pectoris and arrhythmia (Kim Oh-shik et al., 2009, ReSEAT analysis report).
미세먼지에 포함된 다환방향족탄화수소(polycyclic aromatic hydrocarbon, PAH)는 세포 내로 침투되어 공통적으로 아릴 하이드로카본 수용체(Aryl hydrocarbon receptor; AhR)를 활성화시키는 것으로 알려져 있다. AhR 활성화 기전을 통해 세포 내 활성 산소종(Reactive oxygen species; ROS)이 증가되고, 다양한 염증 매개 인자의 발현을 증가시켜 호흡기 질환을 일으키게 된다.It is known that polycyclic aromatic hydrocarbon (PAH) contained in fine dust penetrates into cells and commonly activates aryl hydrocarbon receptor (AhR). Through the AhR activation mechanism, intracellular reactive oxygen species (ROS) are increased, and the expression of various inflammatory mediators is increased to cause respiratory diseases.
전세계적으로 미세먼지에 대한 호흡기 질환의 증가에 따라 세계보건기구(WHO)에서는 2013년 1군 발암물질로 분류하였으며, 우리나라도 그에 맞게 미세먼지 저감 방안 및 치료제 개발이 절실한 상황이다. 대부분의 호흡기 질환 치료제는 단일 성분의 합성 의약품으로, 미세먼지의 경우 종래 성분들이 지역적, 계절적, 시기적, 기후 환경적인 영향에 따라 달라지므로, 다양한 병리 기전에 대한 효과적인 치료가 어렵다는 문제점이 있다. 따라서 미세먼지의 발생빈도가 점차 증가되고 있는 사회적 현상으로 인해 치료제 개발 및 연구가 중요하다고 할 수 있다.Due to the increase in respiratory diseases caused by fine dust worldwide, the World Health Organization (WHO) classified it as a group 1 carcinogen in 2013, and Korea is in dire need of a plan to reduce fine dust and the development of a treatment accordingly. Most respiratory disease treatments are single-component synthetic medicines. In the case of fine dust, conventional ingredients vary depending on regional, seasonal, seasonal, climate and environmental influences, so effective treatment for various pathological mechanisms is difficult. Therefore, it can be said that the development and research of treatments are important due to the social phenomenon in which the frequency of occurrence of fine dust is gradually increasing.
한편, 맥문동(Liriope platyphylla)은 음지 습한 곳에서 잘 자라고, 7월에 보라색의 꽃이 피어 10월에는 검은색 열매를 맺는 백합과에 속하는 다년생 초본식물로서, 맥문동의 효능으로 혈당강하작용, 항염증작용, 항부정맥효과, 항암작용 등이 있는 것으로 보고된 바 있다. 또한 맥문동의 주된 유효성분으로 steroid계 saponin인 ophiopogenine A, B, methylophiopogonone A, B, ophiopogonanone A, methylophiopoginanone A, B 등의 homoisoflavonid류가 함유되어있으며, 그 외 β-sitosterol, stigmasterol, β-sitosterol glucoside, oligosaccarides 등의 다양한 polysaccharides가 괴근의 약 60%이상 함유되어 있는 것으로 보고된 바 있다.On the other hand, Liriope platyphylla is a perennial herbaceous plant belonging to the Liliaceae family that grows well in shady and humid places, blooms purple flowers in July and bears black fruits in October. It has been reported to have antiarrhythmic and anticancer effects. In addition, as the main active ingredient of Macmundong, it contains homoisoflavonids such as ophiopogenine A, B, methylophiopogonone A, B, ophiopogonanone A, methylophiopoginanone A, B, which are steroid saponins, and other β-sitosterol, stigmasterol, β-sitosterol glucoside, It has been reported that about 60% or more of various polysaccharides such as oligosaccharides are contained in tubers.
또한 맥문동 추출물 이외의 천연물의 유익한 성분들을 이용하여 기능성식품 등을 제공함으로써 사회적인 문제로 부상되고 있는 미세먼지에 의해 야기되는 호흡기 질환을 예방 및 치료할 필요성이 있다.In addition, there is a need to prevent and treat respiratory diseases caused by fine dust, which is emerging as a social problem, by providing functional foods using beneficial components of natural products other than extracts of Macundong.
본 발명은 기관지 기능의 개선 또는 면역기능의 증강을 위한 건강기능식품을 제공함에 그 목적이 있다.An object of the present invention is to provide a health functional food for improving bronchial function or enhancing immune function.
본 발명이 이루고자 하는 기술적 과제는 이상에서 언급한 기술적 과제로 제한되지 않으며, 언급되지 않은 또 다른 기술적 과제들은 아래의 기재로부터 당업계 통상의 기술자에게 명확하게 이해될 수 있을 것이다.The technical problem to be achieved by the present invention is not limited to the above-mentioned technical problem, and other technical problems not mentioned will be clearly understood by those skilled in the art from the following description.
본 발명의 일 양태로서, 모과, 감초, 대추 및 도라지를 포함하고, 맥문동, 오미자 또는 이들의 조합을 더 포함하는 혼합물의 추출물을 포함하는, 기관지 기능의 개선 또는 면역기능의 증강을 위한 건강기능식품을 제공한다.As one aspect of the present invention, a health functional food for improving bronchial function or enhancing immune function, comprising an extract of a mixture including quince, licorice, jujube and bellflower, and further including schizandra chinensis, Schisandra chinensis, or a combination thereof provides
용어 '추출물'은 당업계에서 조추출물(crude extract)로 통용되는 의미를 갖지만, 광의적으로 추출물을 추가적으로 분획(fractionation)한 분획물도 포함한다. 즉, 본 발명에서 이용되는 추출물은 추출용매를 이용하여 얻은 것뿐만 아니라 여기에 정제과정을 추가적으로 적용하여 얻은 것도 포함한다. 예컨대, 상기 추출물을 일정한 분자량 컷-오프 값을 갖는 한외 여과막을 통과시켜 얻은 분획, 다양한 크로마토크래피(크기, 전하, 소수성 또는 친화성에 따른 분리를 위해 제작된 것)에 의한 분리 등, 추가적으로 실시된 다양한 정제방법을 통해 얻어진 분획도 본 발명의 추출물에 포함될 수 있다. 또한, 상기 추출물은 감압 증류 및 동결 건조 또는 분무 건조 과 같은 추가적인 과정에 의해 분말 상태로 제조될 수 있다. 상기 추출물을 얻는 방법은 침출법, 교반추출, 초음파추출, 초임계추출, 용매추출, 주정추출, 열수추출법 등이 있으나 이에 제한되지 않는다.The term 'extract' has a meaning commonly used in the art as a crude extract, but also includes a fraction obtained by further fractionating the extract in a broad sense. That is, the extract used in the present invention includes not only those obtained by using an extraction solvent but also those obtained by additionally applying a purification process thereto. For example, a fraction obtained by passing the extract through an ultrafiltration membrane having a certain molecular weight cut-off value, separation by various chromatographies (made for separation according to size, charge, hydrophobicity or affinity), etc. Fractions obtained through various purification methods may also be included in the extract of the present invention. In addition, the extract may be prepared in a powder state by an additional process such as distillation under reduced pressure and freeze drying or spray drying. Methods for obtaining the extract include, but are not limited to, leaching, stirring extraction, ultrasonic extraction, supercritical extraction, solvent extraction, alcohol extraction, and hot water extraction.
상기 추출물은 물, 증류수, 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올, 아세톤, 에테르, 에틸아세테이트, 메틸렌클로라이드, n-헥산, 염산, 초산, 포름산, 디에틸에테르, 사이클로헥산 및 이들의 조합으로 이루어진 군 중에서 선택되는 용매를 이용하여 추출된 것일 수 있다.The extract is water, distilled water, methanol, ethanol, propanol, isopropanol, butanol, acetone, ether, ethyl acetate, methylene chloride, n-hexane, hydrochloric acid, acetic acid, formic acid, diethyl ether, cyclohexane, and combinations thereof It may be extracted using a solvent selected from among.
상기 추출물은 각각 80 내지 150 ℃의 온도에서 30 분 이상 열수추출한 것일 수 있다. 구체적으로는, 80 내지 150℃, 85 내지 145℃, 90 내지 140℃, 95 내지 135℃, 100 내지 130℃, 105 내지 130℃ 또는 110 내지 120℃의 온도에서, 5 내지 15 시간, 5 내지 14 시간, 5 내지 13 시간, 5 내지 12 시간, 5 내지 11 시간, 5 내지 10 시간, 6 내지 15 시간, 6 내지 14 시간, 6 내지 13 시간, 6 내지 12 시간, 6 내지 13 시간, 6 내지 12 시간, 6 내지 11 시간 또는 6 내지 10시간 동안 열수추출한 것일 수 있다.The extract may be obtained by hot water extraction at a temperature of 80 to 150 °C for 30 minutes or more. Specifically, at a temperature of 80 to 150 ° C, 85 to 145 ° C, 90 to 140 ° C, 95 to 135 ° C, 100 to 130 ° C, 105 to 130 ° C or 110 to 120 ° C, 5 to 15 hours, 5 to 14 hour, 5 to 13 hours, 5 to 12 hours, 5 to 11 hours, 5 to 10 hours, 6 to 15 hours, 6 to 14 hours, 6 to 13 hours, 6 to 12 hours, 6 to 13 hours, 6 to 12 hours time, it may be hot water extraction for 6 to 11 hours or 6 to 10 hours.
상기 모과는 상기 혼합물 내 9 내지 30, 9 내지 29, 9 내지 28, 9 내지 27, 9 내지 26, 9 내지 25, 9 내지 24, 9 내지 23, 9 내지 22, 9 내지 21, 9 내지 20, 9 내지 19, 9 내지 18, 9 내지 17, 9 내지 16, 9 내지 15, 9 내지 14, 10 내지 30, 10 내지 29, 10 내지 28, 10 내지 27, 10 내지 26, 10 내지 25, 10 내지 24, 10 내지 23, 10 내지 22, 10 내지 21, 10 내지 20, 10 내지 19, 10 내지 18, 10 내지 17, 10 내지 16, 10 내지 15 또는 10 내지 14 중량%로 포함될 수 있고, 기관지의 건강을 개선함과 동시에 과량의 섭취로 인한 두통이나 현기증의 예방의 측면에서, 바람직한 일 실시예에 따를 때 10 내지 14 중량%로 포함될 수 있으나, 이에 제한되는 것은 아니다.The quince in the mixture 9 to 30, 9 to 29, 9 to 28, 9 to 27, 9 to 26, 9 to 25, 9 to 24, 9 to 23, 9 to 22, 9 to 21, 9 to 20, 9 to 19, 9 to 18, 9 to 17, 9 to 16, 9 to 15, 9 to 14, 10 to 30, 10 to 29, 10 to 28, 10 to 27, 10 to 26, 10 to 25, 10 to 24, 10 to 23, 10 to 22, 10 to 21, 10 to 20, 10 to 19, 10 to 18, 10 to 17, 10 to 16, 10 to 15, or 10 to 14% by weight, bronchial In terms of improving health and preventing headaches or dizziness due to excessive intake at the same time, according to a preferred embodiment, it may be included in 10 to 14% by weight, but is not limited thereto.
상기 감초는 상기 혼합물 내 8 내지 30, 8 내지 29, 8 내지 28, 8 내지 27, 8 내지 26, 8 내지 25, 8 내지 24, 8 내지 23, 8 내지 22, 8 내지 21, 8 내지 20, 8 내지 19, 8 내지 18, 8 내지 17, 8 내지 16, 8 내지 15, 8 내지 14, 8 내지 13, 9 내지 30, 9 내지 29, 9 내지 28, 9 내지 27, 9 내지 26, 9 내지 25, 9 내지 24, 9 내지 23, 9 내지 22, 9 내지 21, 9 내지 20, 9 내지 19, 9 내지 18, 9 내지 17, 9 내지 16, 9 내지 15, 9 내지 14 또는 9 내지 13 중량%로 포함될 수 있고, 유효성분인 글리시리진산을 적절히 함유하면서도 혈압이 높아지는 부작용의 예방 측면에서, 바람직한 일 실시예에 따를 때 9 내지 13 중량%로 포함될 수 있으나, 이에 제한되는 것은 아니다.The licorice is 8 to 30, 8 to 29, 8 to 28, 8 to 27, 8 to 26, 8 to 25, 8 to 24, 8 to 23, 8 to 22, 8 to 21, 8 to 20, 8 to 19, 8 to 18, 8 to 17, 8 to 16, 8 to 15, 8 to 14, 8 to 13, 9 to 30, 9 to 29, 9 to 28, 9 to 27, 9 to 26, 9 to 25, 9 to 24, 9 to 23, 9 to 22, 9 to 21, 9 to 20, 9 to 19, 9 to 18, 9 to 17, 9 to 16, 9 to 15, 9 to 14 or 9 to 13 weight It may be included in %, and may be included in 9 to 13% by weight according to one preferred embodiment in terms of preventing the side effect of increasing blood pressure while properly containing the active ingredient glycyrrhizic acid, but is not limited thereto.
상기 대추는 상기 혼합물 내 7 내지 30, 7 내지 29, 7 내지 28, 7 내지 27, 7 내지 26, 7 내지 25, 7 내지 24, 7 내지 23, 7 내지 22, 7 내지 21, 7 내지 20, 7 내지 19, 7 내지 18, 7 내지 17, 7 내지 16, 7 내지 15, 7 내지 14, 7 내지 13, 7 내지 12, 8 내지 30, 8 내지 29, 8 내지 28, 8 내지 27, 8 내지 26, 8 내지 25, 8 내지 24, 8 내지 23, 8 내지 22, 8 내지 21, 8 내지 20, 8 내지 19, 8 내지 18, 8 내지 17, 8 내지 16, 8 내지 15, 8 내지 14, 8 내지 13 또는 8 내지 12 중량%로 포함될 수 있고, 비타민 C를 적절히 함유하면서도 열이 많은 체질의 복용자로 하여금 부담없이 복용하도록 한다는 측면에서, 바람직한 일 실시예에 따를 때 8 내지 12 중량%로 포함될 수 있으나, 이에 제한되는 것은 아니다.The jujube is 7 to 30, 7 to 29, 7 to 28, 7 to 27, 7 to 26, 7 to 25, 7 to 24, 7 to 23, 7 to 22, 7 to 21, 7 to 20, 7 to 19, 7 to 18, 7 to 17, 7 to 16, 7 to 15, 7 to 14, 7 to 13, 7 to 12, 8 to 30, 8 to 29, 8 to 28, 8 to 27, 8 to 26, 8 to 25, 8 to 24, 8 to 23, 8 to 22, 8 to 21, 8 to 20, 8 to 19, 8 to 18, 8 to 17, 8 to 16, 8 to 15, 8 to 14; It may be included in 8 to 13 or 8 to 12% by weight, and according to a preferred embodiment, it may be included in 8 to 12% by weight in terms of appropriately containing vitamin C and allowing a user with a hot constitution to take it without burden. It may be, but is not limited thereto.
상기 도라지는 6 내지 30, 6 내지 29, 6 내지 28, 6 내지 27, 6 내지 26, 6 내지 25, 6 내지 24, 6 내지 23, 6 내지 22, 6 내지 21, 6 내지 20, 6 내지 19, 6 내지 18, 6 내지 17, 6 내지 16, 6 내지 15, 6 내지 14, 6 내지 13, 6 내지 12, 6 내지 11, 7 내지 30, 7 내지 29, 7 내지 28, 7 내지 27, 7 내지 26, 7 내지 25, 7 내지 24, 7 내지 23, 7 내지 22, 7 내지 21, 7 내지 20, 7 내지 19, 7 내지 18, 7 내지 17, 7 내지 16, 7 내지 15, 7 내지 14, 7 내지 13, 7 내지 12 또는 7 내지 11 중량%로 포함될 수 있고, 유효성분은 사포닌을 적절한 양으로 포함하여 용혈작용을 방지하는 측면에서, 바람직한 일 실시예에 따를 때 7 내지 11 중량%로 포함될 수 있으나, 이에 제한되는 것은 아니다.The bellflower 6 to 30, 6 to 29, 6 to 28, 6 to 27, 6 to 26, 6 to 25, 6 to 24, 6 to 23, 6 to 22, 6 to 21, 6 to 20, 6 to 19 , 6 to 18, 6 to 17, 6 to 16, 6 to 15, 6 to 14, 6 to 13, 6 to 12, 6 to 11, 7 to 30, 7 to 29, 7 to 28, 7 to 27, 7 to 26, 7 to 25, 7 to 24, 7 to 23, 7 to 22, 7 to 21, 7 to 20, 7 to 19, 7 to 18, 7 to 17, 7 to 16, 7 to 15, 7 to 14 , 7 to 13, 7 to 12, or 7 to 11% by weight, and the active ingredient includes saponin in an appropriate amount to prevent hemolysis, and according to a preferred embodiment, 7 to 11% by weight It may include, but is not limited thereto.
상기 맥문동은 이의 잎, 줄기, 뿌리, 씨앗, 열매 등 부위를 특별히 가리지 아니하고, 바람직한 일 실시예에 따를 때 이의 뿌리일 수 있다. 상기 맥문동은 6 내지 30, 6 내지 29, 6 내지 28, 6 내지 27, 6 내지 26, 6 내지 25, 6 내지 24, 6 내지 23, 6 내지 22, 6 내지 21, 6 내지 20, 6 내지 19, 6 내지 18, 6 내지 17, 6 내지 16, 6 내지 15, 6 내지 14, 6 내지 13, 6 내지 12, 6 내지 11, 7 내지 30, 7 내지 29, 7 내지 28, 7 내지 27, 7 내지 26, 7 내지 25, 7 내지 24, 7 내지 23, 7 내지 22, 7 내지 21, 7 내지 20, 7 내지 19, 7 내지 18, 7 내지 17, 7 내지 16, 7 내지 15, 7 내지 14, 7 내지 13, 7 내지 12 또는 7 내지 11 중량%로 포함될 수 있고, 기관지와 폐의 건강을 개선하면서도 과량 섭취로 인한 복통이나 설사를 예방하는 측면에서, 바람직한 일 실시예에 따를 때 7 내지 11 중량%로 포함될 수 있으나, 이에 제한되는 것은 아니다.The rhizomes do not specifically cover their leaves, stems, roots, seeds, fruits, etc., and according to a preferred embodiment, they may be their roots. 6 to 30, 6 to 29, 6 to 28, 6 to 27, 6 to 26, 6 to 25, 6 to 24, 6 to 23, 6 to 22, 6 to 21, 6 to 20, 6 to 19 , 6 to 18, 6 to 17, 6 to 16, 6 to 15, 6 to 14, 6 to 13, 6 to 12, 6 to 11, 7 to 30, 7 to 29, 7 to 28, 7 to 27, 7 to 26, 7 to 25, 7 to 24, 7 to 23, 7 to 22, 7 to 21, 7 to 20, 7 to 19, 7 to 18, 7 to 17, 7 to 16, 7 to 15, 7 to 14 , 7 to 13, 7 to 12, or 7 to 11% by weight, in terms of preventing abdominal pain or diarrhea due to excessive intake while improving bronchial and lung health, according to a preferred embodiment, 7 to 11 It may be included in weight percent, but is not limited thereto.
상기 오미자는 이의 잎, 줄기, 뿌리, 씨앗, 열매 등 부위를 특별히 가리지 아니하고, 바람직한 일 실시예에 따를 때 이의 열매일 수 있다. 상기 오미자는 6 내지 30, 6 내지 29, 6 내지 28, 6 내지 27, 6 내지 26, 6 내지 25, 6 내지 24, 6 내지 23, 6 내지 22, 6 내지 21, 6 내지 20, 6 내지 19, 6 내지 18, 6 내지 17, 6 내지 16, 6 내지 15, 6 내지 14, 6 내지 13, 6 내지 12, 6 내지 11, 7 내지 30, 7 내지 29, 7 내지 28, 7 내지 27, 7 내지 26, 7 내지 25, 7 내지 24, 7 내지 23, 7 내지 22, 7 내지 21, 7 내지 20, 7 내지 19, 7 내지 18, 7 내지 17, 7 내지 16, 7 내지 15, 7 내지 14, 7 내지 13, 7 내지 12 또는 7 내지 11 중량%로 포함될 수 있고, 호흡기 질환의 대표증상을 완화시키면서도 위의 건강이 좋지 않은 사람도 부담없이 복용할 수 있도록 하는 측면에서, 바람직한 일 실시예에 따를 때 7 내지 11 중량%로 포함될 수 있으나, 이에 제한되는 것은 아니다.The Schizandra chinensis does not particularly cover its leaves, stems, roots, seeds, fruits, etc., and may be its fruit according to a preferred embodiment. The Schizandra chinensis 6 to 30, 6 to 29, 6 to 28, 6 to 27, 6 to 26, 6 to 25, 6 to 24, 6 to 23, 6 to 22, 6 to 21, 6 to 20, 6 to 19 , 6 to 18, 6 to 17, 6 to 16, 6 to 15, 6 to 14, 6 to 13, 6 to 12, 6 to 11, 7 to 30, 7 to 29, 7 to 28, 7 to 27, 7 to 26, 7 to 25, 7 to 24, 7 to 23, 7 to 22, 7 to 21, 7 to 20, 7 to 19, 7 to 18, 7 to 17, 7 to 16, 7 to 15, 7 to 14 , 7 to 13, 7 to 12, or 7 to 11% by weight, in terms of alleviating the representative symptoms of respiratory diseases and allowing people with poor health to take it without burden, in one preferred embodiment When followed, it may be included in 7 to 11% by weight, but is not limited thereto.
상기 혼합물은 더덕, 작두콩 또는 이들의 조합을 더 포함할 수 있다.The mixture may further include deodeok, small beans, or a combination thereof.
상기 더덕은 4 내지 30, 4 내지 29, 4 내지 28, 4 내지 27, 4 내지 26, 4 내지 25, 4 내지 24, 4 내지 23, 4 내지 22, 4 내지 21, 4 내지 20, 4 내지 19, 4 내지 18, 4 내지 17, 4 내지 16, 4 내지 15, 4 내지 14, 4 내지 13, 4 내지 12, 4 내지 11, 4 내지 10, 4 내지 9, 5 내지 30, 5 내지 29, 5 내지 28, 5 내지 27, 5 내지 26, 5 내지 25, 5 내지 24, 5 내지 23, 5 내지 22, 5 내지 21, 5 내지 20, 5 내지 19, 5 내지 18, 5 내지 17, 5 내지 16, 5 내지 15, 5 내지 14, 5 내지 13, 5 내지 12, 5 내지 11, 5 내지 10 또는 5 내지 9 중량%로 포함될 수 있고, 도라지 내 포함된 사포닌의 함량을 고려하여 적절량의 추가 사포닌을 공급한다는 측면에서, 바람직한 일 실시예에 따를 때 5 내지 9 중량%로 포함될 수 있으나, 이에 제한되는 것은 아니다.The deodeok is 4 to 30, 4 to 29, 4 to 28, 4 to 27, 4 to 26, 4 to 25, 4 to 24, 4 to 23, 4 to 22, 4 to 21, 4 to 20, 4 to 19 , 4 to 18, 4 to 17, 4 to 16, 4 to 15, 4 to 14, 4 to 13, 4 to 12, 4 to 11, 4 to 10, 4 to 9, 5 to 30, 5 to 29, 5 to 28, 5 to 27, 5 to 26, 5 to 25, 5 to 24, 5 to 23, 5 to 22, 5 to 21, 5 to 20, 5 to 19, 5 to 18, 5 to 17, 5 to 16 , 5 to 15, 5 to 14, 5 to 13, 5 to 12, 5 to 11, 5 to 10, or 5 to 9% by weight, considering the content of saponin contained in bellflower, an appropriate amount of additional saponin In terms of supplying, according to a preferred embodiment, it may be included in 5 to 9% by weight, but is not limited thereto.
상기 작두콩은 4 내지 30, 4 내지 29, 4 내지 28, 4 내지 27, 4 내지 26, 4 내지 25, 4 내지 24, 4 내지 23, 4 내지 22, 4 내지 21, 4 내지 20, 4 내지 19, 4 내지 18, 4 내지 17, 4 내지 16, 4 내지 15, 4 내지 14, 4 내지 13, 4 내지 12, 4 내지 11, 4 내지 10, 4 내지 9, 5 내지 30, 5 내지 29, 5 내지 28, 5 내지 27, 5 내지 26, 5 내지 25, 5 내지 24, 5 내지 23, 5 내지 22, 5 내지 21, 5 내지 20, 5 내지 19, 5 내지 18, 5 내지 17, 5 내지 16, 5 내지 15, 5 내지 14, 5 내지 13, 5 내지 12, 5 내지 11, 5 내지 10 또는 5 내지 9 중량%로 포함될 수 있고, 비염이나 알레르기와 같은 증상의 개선과 동시에 대장의 건강이 좋지 않은 사람도 부담없이 복용할 수 있도록 하는 측면에서, 바람직한 일 실시예에 따를 때 5 내지 9 중량%로 포함될 수 있으나, 이에 제한되는 것은 아니다.The beans are 4 to 30, 4 to 29, 4 to 28, 4 to 27, 4 to 26, 4 to 25, 4 to 24, 4 to 23, 4 to 22, 4 to 21, 4 to 20, 4 to 19 , 4 to 18, 4 to 17, 4 to 16, 4 to 15, 4 to 14, 4 to 13, 4 to 12, 4 to 11, 4 to 10, 4 to 9, 5 to 30, 5 to 29, 5 to 28, 5 to 27, 5 to 26, 5 to 25, 5 to 24, 5 to 23, 5 to 22, 5 to 21, 5 to 20, 5 to 19, 5 to 18, 5 to 17, 5 to 16 , 5 to 15, 5 to 14, 5 to 13, 5 to 12, 5 to 11, 5 to 10, or 5 to 9% by weight, improving symptoms such as rhinitis or allergies and poor health of the large intestine at the same time In terms of allowing even non-skilled people to take it without burden, according to a preferred embodiment, it may be included in 5 to 9% by weight, but is not limited thereto.
상기 혼합물은 박하, 삼백초 또는 이들의 조합을 더 포함할 수 있다.The mixture may further include peppermint, triticale, or a combination thereof.
상기 박하는 박하나무의 잎, 줄기, 뿌리, 씨앗, 열매 등 부위를 특별히 가리지 아니하고, 바람직한 일 실시예에 따를 때 이의 잎일 수 있다. 상기 박하는 3 내지 30, 3 내지 29, 3 내지 28, 3 내지 27, 3 내지 26, 3 내지 25, 3 내지 24, 3 내지 23, 3 내지 22, 3 내지 21, 3 내지 20, 3 내지 19, 3 내지 18, 3 내지 17, 3 내지 16, 3 내지 15, 3 내지 14, 3 내지 13, 3 내지 12, 3 내지 11, 3 내지 10, 3 내지 9, 3 내지 8, 4 내지 30, 4 내지 29, 4 내지 28, 4 내지 27, 4 내지 26, 4 내지 25, 4 내지 24, 4 내지 23, 4 내지 22, 4 내지 21, 4 내지 20, 4 내지 19, 4 내지 18, 4 내지 17, 4 내지 16, 4 내지 15, 4 내지 14, 4 내지 13, 4 내지 12, 4 내지 11, 4 내지 10, 4 내지 9 또는 4 내지 8 중량%로 포함될 수 있고, 감기로 인한 기침과 유사한 제반증상을 완화시킴과 동시에 역류성 식도염 등을 앓고 있는 사람도 부담없이 복용하도록 하는 측면에서, 바람직한 일 실시예에 따를 때 4 내지 8 중량%로 포함될 수 있으나, 이에 제한되는 것은 아니다.The peppermint does not particularly cover parts such as leaves, stems, roots, seeds, and fruits of the peppermint tree, and according to a preferred embodiment, it may be its leaves. The mint is 3 to 30, 3 to 29, 3 to 28, 3 to 27, 3 to 26, 3 to 25, 3 to 24, 3 to 23, 3 to 22, 3 to 21, 3 to 20, 3 to 19 , 3 to 18, 3 to 17, 3 to 16, 3 to 15, 3 to 14, 3 to 13, 3 to 12, 3 to 11, 3 to 10, 3 to 9, 3 to 8, 4 to 30, 4 to 29, 4 to 28, 4 to 27, 4 to 26, 4 to 25, 4 to 24, 4 to 23, 4 to 22, 4 to 21, 4 to 20, 4 to 19, 4 to 18, 4 to 17 , 4 to 16, 4 to 15, 4 to 14, 4 to 13, 4 to 12, 4 to 11, 4 to 10, 4 to 9 or 4 to 8% by weight, all similar to cough caused by a cold In terms of alleviating symptoms and at the same time allowing people suffering from reflux esophagitis to take it without burden, according to a preferred embodiment, it may be included in 4 to 8% by weight, but is not limited thereto.
상기 삼백초는 이의 잎, 줄기, 뿌리, 씨앗, 열매 등 부위를 특별히 가리지 아니하고, 바람직한 일 실시예에 따를 때 이의 잎일 수 있다. 상기 삼백초는 3 내지 30, 3 내지 29, 3 내지 28, 3 내지 27, 3 내지 26, 3 내지 25, 3 내지 24, 3 내지 23, 3 내지 22, 3 내지 21, 3 내지 20, 3 내지 19, 3 내지 18, 3 내지 17, 3 내지 16, 3 내지 15, 3 내지 14, 3 내지 13, 3 내지 12, 3 내지 11, 3 내지 10, 3 내지 9, 3 내지 8, 4 내지 30, 4 내지 29, 4 내지 28, 4 내지 27, 4 내지 26, 4 내지 25, 4 내지 24, 4 내지 23, 4 내지 22, 4 내지 21, 4 내지 20, 4 내지 19, 4 내지 18, 4 내지 17, 4 내지 16, 4 내지 15, 4 내지 14, 4 내지 13, 4 내지 12, 4 내지 11, 4 내지 10, 4 내지 9 또는 4 내지 8 중량%로 포함될 수 있고, 각종 염증반응의 개선과 동시에 과량 섭취로 인한 설사 등을 예방하는 측면에서, 바람직한 일 실시예에 따를 때 4 내지 8 중량%로 포함될 수 있으나, 이에 제한되는 것은 아니다.The 300 seconds does not specifically cover its leaves, stems, roots, seeds, fruits, etc., and according to a preferred embodiment, it may be its leaves. 3 to 30, 3 to 29, 3 to 28, 3 to 27, 3 to 26, 3 to 25, 3 to 24, 3 to 23, 3 to 22, 3 to 21, 3 to 20, 3 to 19 , 3 to 18, 3 to 17, 3 to 16, 3 to 15, 3 to 14, 3 to 13, 3 to 12, 3 to 11, 3 to 10, 3 to 9, 3 to 8, 4 to 30, 4 to 29, 4 to 28, 4 to 27, 4 to 26, 4 to 25, 4 to 24, 4 to 23, 4 to 22, 4 to 21, 4 to 20, 4 to 19, 4 to 18, 4 to 17 , 4 to 16, 4 to 15, 4 to 14, 4 to 13, 4 to 12, 4 to 11, 4 to 10, 4 to 9 or 4 to 8% by weight may be included, while improving various inflammatory reactions In terms of preventing diarrhea due to excessive intake, according to a preferred embodiment, it may be included in 4 to 8% by weight, but is not limited thereto.
상기 혼합물은 생강, 느릅나무 껍질 또는 이들의 조합을 더 포함할 수 있다.The mixture may further include ginger, elm bark, or a combination thereof.
상기 생강은 2 내지 30, 2 내지 29, 2 내지 28, 2 내지 27, 2 내지 26, 2 내지 25, 2 내지 24, 2 내지 23, 2 내지 22, 2 내지 21, 2 내지 20, 2 내지 19, 2 내지 18, 2 내지 17, 2 내지 16, 2 내지 15, 2 내지 14, 2 내지 13, 2 내지 12, 2 내지 11, 2 내지 10, 2 내지 9, 2 내지 8, 2 내지 7, 3 내지 30, 3 내지 29, 3 내지 28, 3 내지 27, 3 내지 26, 3 내지 25, 3 내지 24, 3 내지 23, 3 내지 22, 3 내지 21, 3 내지 20, 3 내지 19, 3 내지 18, 3 내지 17, 3 내지 16, 3 내지 15, 3 내지 14, 3 내지 13, 3 내지 12, 3 내지 11, 3 내지 10, 3 내지 9, 3 내지 8 또는 3 내지 7 중량%로 포함될 수 있고, 생강 내 포함된 유효성분을 통한 면역기능의 강화와 동시에 과도한 위의 자극을 예방하는 측면에서, 바람직한 일 실시예에 따를 때 3 내지 7 중량%로 포함될 수 있으나, 이에 제한되는 것은 아니다.The ginger is 2 to 30, 2 to 29, 2 to 28, 2 to 27, 2 to 26, 2 to 25, 2 to 24, 2 to 23, 2 to 22, 2 to 21, 2 to 20, 2 to 19 , 2 to 18, 2 to 17, 2 to 16, 2 to 15, 2 to 14, 2 to 13, 2 to 12, 2 to 11, 2 to 10, 2 to 9, 2 to 8, 2 to 7, 3 to 30, 3 to 29, 3 to 28, 3 to 27, 3 to 26, 3 to 25, 3 to 24, 3 to 23, 3 to 22, 3 to 21, 3 to 20, 3 to 19, 3 to 18 , 3 to 17, 3 to 16, 3 to 15, 3 to 14, 3 to 13, 3 to 12, 3 to 11, 3 to 10, 3 to 9, 3 to 8 or 3 to 7% by weight, and , In terms of strengthening the immune function through the active ingredient contained in ginger and preventing excessive stimulation of the stomach at the same time, according to a preferred embodiment, it may be included in 3 to 7% by weight, but is not limited thereto.
상기 느릅나무 껍질은 2 내지 30, 2 내지 29, 2 내지 28, 2 내지 27, 2 내지 26, 2 내지 25, 2 내지 24, 2 내지 23, 2 내지 22, 2 내지 21, 2 내지 20, 2 내지 19, 2 내지 18, 2 내지 17, 2 내지 16, 2 내지 15, 2 내지 14, 2 내지 13, 2 내지 12, 2 내지 11, 2 내지 10, 2 내지 9, 2 내지 8, 2 내지 7, 3 내지 30, 3 내지 29, 3 내지 28, 3 내지 27, 3 내지 26, 3 내지 25, 3 내지 24, 3 내지 23, 3 내지 22, 3 내지 21, 3 내지 20, 3 내지 19, 3 내지 18, 3 내지 17, 3 내지 16, 3 내지 15, 3 내지 14, 3 내지 13, 3 내지 12, 3 내지 11, 3 내지 10, 3 내지 9, 3 내지 8 또는 3 내지 7 중량%로 포함될 수 있고, 알레르기 반응의 효과적인 개선과 동시에 과량 섭취로 인한 간에의 부작용을 예방하는 측면에서, 바람직한 일 실시예에 따를 때 3 내지 7 중량%로 포함될 수 있으나, 이에 제한되는 것은 아니다.The elm bark is 2 to 30, 2 to 29, 2 to 28, 2 to 27, 2 to 26, 2 to 25, 2 to 24, 2 to 23, 2 to 22, 2 to 21, 2 to 20, 2 to 19, 2 to 18, 2 to 17, 2 to 16, 2 to 15, 2 to 14, 2 to 13, 2 to 12, 2 to 11, 2 to 10, 2 to 9, 2 to 8, 2 to 7 , 3 to 30, 3 to 29, 3 to 28, 3 to 27, 3 to 26, 3 to 25, 3 to 24, 3 to 23, 3 to 22, 3 to 21, 3 to 20, 3 to 19, 3 to 18, 3 to 17, 3 to 16, 3 to 15, 3 to 14, 3 to 13, 3 to 12, 3 to 11, 3 to 10, 3 to 9, 3 to 8 or 3 to 7% by weight. In terms of effectively improving allergic reactions and preventing side effects on the liver due to excessive intake at the same time, according to a preferred embodiment, it may be included in 3 to 7% by weight, but is not limited thereto.
상기 혼합물은 영지버섯을 더 포함할 수 있다.The mixture may further include ganoderma lucidum.
상기 영지버섯은 1 내지 30, 1 내지 29, 1 내지 28, 1 내지 27, 1 내지 26, 1 내지 25, 1 내지 24, 1 내지 23, 1 내지 22, 1 내지 21, 1 내지 20, 1 내지 19, 1 내지 18, 1 내지 17, 1 내지 16, 1 내지 15, 1 내지 14, 1 내지 13, 1 내지 12, 1 내지 11, 1 내지 10, 1 내지 9, 1 내지 8, 1 내지 7, 1 내지 6, 2 내지 30, 2 내지 29, 2 내지 28, 2 내지 27, 2 내지 26, 2 내지 25, 2 내지 24, 2 내지 23, 2 내지 22, 2 내지 21, 2 내지 20, 2 내지 19, 2 내지 18, 2 내지 17, 2 내지 16, 2 내지 15, 2 내지 14, 2 내지 13, 2 내지 12, 2 내지 11, 2 내지 10, 2 내지 9, 2 내지 8, 2 내지 7 또는 2 내지 6 중량%로 포함될 수 있고, 기관지 건강의 개선과 동시에 과량 섭취로 인한 변비 유발 부작용을 예방하는 측면에서, 바람직한 일 실시예에 따를 때 2 내지 6 중량%로 포함될 수 있으나, 이에 제한되는 것은 아니다.The ganoderma lucidum is 1 to 30, 1 to 29, 1 to 28, 1 to 27, 1 to 26, 1 to 25, 1 to 24, 1 to 23, 1 to 22, 1 to 21, 1 to 20, 1 to 19, 1 to 18, 1 to 17, 1 to 16, 1 to 15, 1 to 14, 1 to 13, 1 to 12, 1 to 11, 1 to 10, 1 to 9, 1 to 8, 1 to 7, 1 to 6, 2 to 30, 2 to 29, 2 to 28, 2 to 27, 2 to 26, 2 to 25, 2 to 24, 2 to 23, 2 to 22, 2 to 21, 2 to 20, 2 to 19, 2 to 18, 2 to 17, 2 to 16, 2 to 15, 2 to 14, 2 to 13, 2 to 12, 2 to 11, 2 to 10, 2 to 9, 2 to 8, 2 to 7 or It may be included in 2 to 6% by weight, in terms of improving bronchial health and at the same time preventing side effects of constipation caused by excessive intake, according to a preferred embodiment, it may be included in 2 to 6% by weight, but is limited thereto no.
상기 건강기능식품은 정제, 캅셀, 분말, 과립, 액상, 환 등의 형태의 식품으로 제조 및 가공할 수 있다.The health functional food can be manufactured and processed into food in the form of tablets, capsules, powders, granules, liquids, pills, and the like.
상기 건강기능식품이라 함은, 건강기능식품에 관한 법률 제6727호에 따른 인체에 유용한 기능성을 가진 원료나 성분을 사용하여 제조 및 가공한 것일 수 있고, 이는 인체의 구조 및 기능에 대하여 영양소를 조절하거나 생리학적 작용 등과 같은 보건 용도에 유용한 효과를 얻을 목적으로 섭취하는 것을 의미한다.The health functional food may be manufactured and processed using raw materials or ingredients having useful functionalities for the human body according to the Health Functional Food Act No. 6727, which regulates nutrients for the structure and function of the human body. It refers to intake for the purpose of obtaining useful effects for health purposes, such as health or physiological actions.
상기 건강기능식품은 통상의 식품 첨가물을 포함할 수 있으며, 식품 첨가물로서의 적합 여부는 다른 규정이 없는 한, 식품의약품안전청에 승인된 식품 첨가물 공전의 총칙 및 일반시험법 등에 따라 해당 품목에 관한 규격 및 기준에 의하여 판정한다.The health functional food may contain normal food additives, and the suitability as a food additive is determined according to the general rules and general test methods of food additives approved by the Korea Food and Drug Administration, unless otherwise specified. judged by criteria.
상기 식품 첨가물 공전에 수재된 품목으로는 예를 들어, 케톤류, 글리신, 구연산칼슘, 니코틴산, 계피산 등의 화학적 합성물; 감색소, 감초추출물, 결정셀룰로오스, 고량색소, 구아검 등의 천연첨가물; L-글루타민산나트륨 제제, 면류첨가알칼리제, 보존료제제, 타르색소제제 등의 혼합제제류 등을 포함하나, 이에 제한되지 않는다.Items listed in the Food Additives Codex include, for example, chemical compounds such as ketones, glycine, calcium citrate, nicotinic acid, and cinnamic acid; natural additives such as persimmon pigment, licorice extract, crystalline cellulose, kaoliang pigment, and guar gum; It includes, but is not limited to, mixed preparations such as sodium L-glutamate preparations, noodle-added alkali preparations, preservative preparations, and tar color preparations.
예를 들어, 정제 형태의 건강기능식품은 상기 유효물질을 부형제, 결합제, 붕해제 및 다른 첨가제와 혼합한 혼합물을 통상의 방법으로 과립화한 다음, 활택제 등을 넣어 압축성형하거나, 상기 혼합물을 직접 압축 성형할 수 있다. 또한 상기 정제 형태의 건강기능식품은 필요에 따라 교미제 등을 함유할 수도 있다.For example, a health functional food in the form of a tablet is obtained by granulating a mixture obtained by mixing the active substance with an excipient, a binder, a disintegrant, and other additives in a conventional manner, and then compression molding by adding a lubricant or the like, or It can be directly compression molded. In addition, the health functional food in the form of a tablet may contain a flavoring agent and the like as needed.
캅셀 형태의 건강기능식품 중 경질 캅셀제는 통상의 경질 캅셀에 본 발명의 펩타이드를 부형제 등의 첨가제와 혼합한 혼합물을 충진하여 제조할 수 있으며, 연질 캅셀제는 상기 유효물질을 부형제 등의 첨가제와 혼합한 혼합물을 젤라틴과 같은 캅셀기제에 충진하여 제조할 수 있다. 상기 연질 캅셀제는 필요에 따라 글리세린 또는 소르비톨 등의 가소제, 착색제, 보존제 등을 함유할 수 있다.Among health functional foods in the form of capsules, hard capsules can be prepared by filling ordinary hard capsules with a mixture of the peptide of the present invention mixed with additives such as excipients, and soft capsules are prepared by mixing the active substances with additives such as excipients. It can be prepared by filling the mixture into a capsule base such as gelatin. The soft capsule may contain a plasticizer such as glycerin or sorbitol, a colorant, a preservative, and the like, if necessary.
환 형태의 건강기능식품은 상기 유효물질과 부형제, 결합제, 붕해제 등을 혼합한 혼합물을 기존에 공지된 방법으로 성형하여 조제할 수 있으며, 필요에 따라 백당이나 다른 제피제로 제피할 수 있으며, 또는 전분, 탈크와 같은 물질로 표면을 코팅할 수도 있다.The health functional food in the form of a pill can be prepared by molding a mixture of the above active substances, excipients, binders, disintegrants, etc. by a conventionally known method, and, if necessary, can be coated with sucrose or other coating agents, or The surface can also be coated with a material such as starch or talc.
과립 형태의 건강기능식품은 상기 유효물질과 부형제, 결합제, 붕해제 등을 혼합한 혼합물을 기존에 공지된 방법으로 입상으로 제조할 수 있으며, 필요에 따라 착향제, 교미제 등을 함유할 수 있다.Health functional food in the form of granules can be prepared in a granular form by a conventionally known method of a mixture of the above active substances, excipients, binders, disintegrants, etc., and may contain flavoring agents, flavoring agents, etc., if necessary. .
상기 건강기능식품은 음료류, 육류, 초코렛, 식품류, 과자류. 피자, 라면, 기타 면류, 껌류, 사탕류, 아이스크림류, 알코올 음료류, 비타민 복함제 및 건강보조식품류 등일 수 있다.The health functional food is beverages, meat, chocolate, foods, confectionery. It may be pizza, ramen, other noodles, chewing gum, candy, ice cream, alcoholic beverages, vitamin complexes and health supplements.
본 발명의 건강기능식품은 모과, 감초, 대추 및 도라지를 필수적 구성요소로 포함하고 있어, 기관지 기능의 개선 또는 면역기능의 증강 효과가 매우 우수하다.The health functional food of the present invention contains quince, licorice, jujube and bellflower as essential components, and thus has a very excellent effect of improving bronchial function or enhancing immune function.
다만, 상기한 효과로 한정되는 것은 아니며, 상세한 설명 또는 청구범위에 기재된 발명의 구성으로부터 추론 가능한 모든 효과를 포함하는 것으로 이해되어야 한다.However, it should be understood that it is not limited to the above effects, and includes all effects that can be inferred from the configuration of the invention described in the detailed description or claims.
이하, 보다 구체적으로 설명하기 위해 실시예를 들어 상세하게 설명하기로 한다. 그러나, 하기 실시예는 예시적인 것으로, 본 발명의 범위가 이에 제한되는 것은 아니다.Hereinafter, an example will be described in detail for a more detailed explanation. However, the following examples are illustrative, and the scope of the present invention is not limited thereto.
실시예. 본 발명 건강기능식품의 제조Example. Manufacture of health functional food of the present invention
본 발명 건강기능식품의 제조를 위해, 모과 120g, 감초 110g, 대추 100g, 도라지 90g, 맥문동 뿌리 90g, 오미자 열매 90g, 더덕 70g, 작두콩 70g, 박하 잎 60g, 삼백초 60g, 생강 50g, 느릅나무 껍질 50g 및 영지버섯 40g을 세척하여 준비하였다. 추출용매로서 10L의 물을 사용하였다.For the production of the health functional food of the present invention, 120 g of quince, 110 g of licorice, 100 g of jujube, 90 g of bellflower root, 90 g of root of Schisandra chinensis, 90 g of fruit of Schisandra chinensis, 70 g of deodeok, 70 g of soybean, 60 g of mint leaf, 60 g of Sambaekcho, 50 g of ginger, 50 g of elm bark and 40 g of ganoderma lucidum was prepared by washing. 10 L of water was used as an extraction solvent.
이 후, 10L의 물과 모과 120g, 감초 110g, 대추 100g, 도라지 90g 및 맥문동 뿌리 90g를 약탕기에 넣고, 120℃에서 8시간 동안 추출하여 본 발명 건강기능식품을 제조하였다(실시예 1).Thereafter, 10L of water, 120g of Chinese quince, 110g of licorice, 100g of jujube, 90g of bellflower root, and 90g of root of rhododendron were placed in a water heater and extracted at 120° C. for 8 hours to prepare the health functional food of the present invention (Example 1).
또한, 10L의 물과 모과 120g, 감초 110g, 대추 100g, 도라지 90g, 맥문동 뿌리 90g 및 오미자 열매 90g를 약탕기에 넣고, 120℃에서 8시간 동안 추출하여 본 발명 건강기능식품을 제조하였다(실시예 2).In addition, 10L of water and 120g of Chinese quince, 110g of licorice, 100g of jujube, 90g of bellflower root, 90g of root of Schisandra chinensis, and 90g of fruit of Schisandra chinensis were placed in a water heater and extracted at 120° C. for 8 hours to prepare the health functional food of the present invention (Example 2 ).
또한, 10L의 물과 모과 120g, 감초 110g, 대추 100g, 도라지 90g, 맥문동 뿌리 90g, 오미자 열매 90g 및 더덕 70g를 약탕기에 넣고, 120℃에서 8시간 동안 추출하여 본 발명 건강기능식품을 제조하였다(실시예 3).In addition, 10 L of water and 120 g of quince, 110 g of licorice, 100 g of jujube, 90 g of bellflower root, 90 g of root of Schisandra chinensis, 90 g of fruit of Schizandra chinensis, and 70 g of deodeok were placed in a water heater and extracted at 120 ° C. for 8 hours to prepare the health functional food of the present invention ( Example 3).
또한, 10L의 물과 모과 120g, 감초 110g, 대추 100g, 도라지 90g, 맥문동 뿌리 90g, 오미자 열매 90g, 더덕 70g 및 작두콩 70g를 약탕기에 넣고, 120℃에서 8시간 동안 추출하여 본 발명 건강기능식품을 제조하였다(실시예 4).In addition, 10L of water and 120g of quince, 110g of licorice, 100g of jujube, 90g of bellflower root, 90g of root of Schisandra chinensis, 90g of fruit of Schizandra chinensis, 70g of deodeok and 70g of soybean were put in a water heater and extracted at 120°C for 8 hours to obtain the health functional food of the present invention. prepared (Example 4).
또한, 10L의 물과 모과 120g, 감초 110g, 대추 100g, 도라지 90g, 맥문동 뿌리 90g, 오미자 열매 90g, 더덕 70g, 작두콩 70g 및 박하 잎 60g를 약탕기에 넣고, 120℃에서 8시간 동안 추출하여 본 발명 건강기능식품을 제조하였다(실시예 5).In addition, 10L of water and 120g of quince, 110g of licorice, 100g of jujube, 90g of bellflower, 90g of rhubarb root, 90g of Schisandra chinensis fruit, 70g of deodeok, 70g of green bean and 60g of mint leaf were put in a water heater, and extracted at 120° C. for 8 hours to extract the present invention. A health functional food was prepared (Example 5).
또한, 10L의 물과 모과 120g, 감초 110g, 대추 100g, 도라지 90g, 맥문동 뿌리 90g, 오미자 열매 90g, 더덕 70g, 작두콩 70g, 박하 잎 60g 및 삼백초 60g를 약탕기에 넣고, 120℃에서 8시간 동안 추출하여 본 발명 건강기능식품을 제조하였다(실시예 6).In addition, 10L of water, 120g of quince, 110g of licorice, 100g of jujube, 90g of bellflower, 90g of rhubarb root, 90g of Schisandra chinensis fruit, 70g of deodeok, 70g of green bean, 60g of mint leaves and 60g of Sambaekcho were put in a water heater and extracted at 120°C for 8 hours. Thus, the health functional food of the present invention was prepared (Example 6).
또한, 10L의 물과 모과 120g, 감초 110g, 대추 100g, 도라지 90g, 맥문동 뿌리 90g, 오미자 열매 90g, 더덕 70g, 작두콩 70g, 박하 잎 60g, 삼백초 60g 및 생강 50g를 약탕기에 넣고, 120℃에서 8시간 동안 추출하여 본 발명 건강기능식품을 제조하였다(실시예 7).In addition, 10L of water and 120g of quince, 110g of licorice, 100g of jujube, 90g of bellflower root, 90g of macmundong root, 90g of Schizandra fruit, 70g of deodeok, 70g of soybean, 60g of mint leaf, 60g of Sambaekcho, and 50g of ginger were put in a water heater, and 8 at 120 ° C. The health functional food of the present invention was prepared by extraction for a period of time (Example 7).
또한, 10L의 물과 모과 120g, 감초 110g, 대추 100g, 도라지 90g, 맥문동 뿌리 90g, 오미자 열매 90g, 더덕 70g, 작두콩 70g, 박하 잎 60g, 삼백초 60g, 생강 50g 및 느릅나무 껍질 50g를 약탕기에 넣고, 120℃에서 8시간 동안 추출하여 본 발명 건강기능식품을 제조하였다(실시예 8).In addition, 10L of water, 120g of quince, 110g of licorice, 100g of jujube, 90g of bellflower root, 90g of root of Schisandra chinensis, 90g of fruit of Schisandra chinensis, 70g of deodeok, 70g of soybean, 60g of mint leaves, 60g of sambaccho, 50g of ginger and 50g of elm bark were put in a water heater , The health functional food of the present invention was prepared by extraction at 120 ° C. for 8 hours (Example 8).
또한, 10L의 물과 모과 120g, 감초 110g, 대추 100g, 도라지 90g, 맥문동 뿌리 90g, 오미자 열매 90g, 더덕 70g, 작두콩 70g, 박하 잎 60g, 삼백초 60g, 생강 50g, 느릅나무 껍질 50g 및 영지버섯 40g를 약탕기에 넣고, 120℃에서 8시간 동안 추출하여 본 발명 건강기능식품을 제조하였다(실시예 9).In addition, 10L of water and quince 120g, licorice 110g, jujube 100g, bellflower 90g, macmundong root 90g, omija fruit 90g, deodeok 70g, soy bean 70g, mint leaf 60g, sachincho 60g, ginger 50g, elm bark 50g, and ganoderma lucidum 40g was placed in a water heater and extracted at 120 ° C. for 8 hours to prepare the health functional food of the present invention (Example 9).
실험예 1. 기관지 기능 개선 효능 평가Experimental Example 1. Evaluation of bronchial function improvement efficacy
실시예 1 내지 9에 대하여 알레르기 비염환자, 흡연자 및 기관지 질환자 각 20명씩 총 180명을 시험 대상으로 하여 1일 2~3회 1포씩 3개월간 음용하게 하고 각자가 느끼는 정도에 따라 비염, 가래 및 기관지 기능(기침 빈도)의 개선 효과에 대하여 9점 채점법(9: 완치에 가까운 효과가 있음, 7: 상당한 개선 효과가 좋음, 5: 개선 효과가 다소 있음, 3: 개선 효과가 미미함. 1: 개선 효과가 없음)을 이용하여 평가하였으며, 그 결과를 하기 표 1에 나타내었다.For Examples 1 to 9, a total of 180 people, 20 each of allergic rhinitis patients, smokers, and bronchial disease subjects, were allowed to drink 1 pack 2-3 times a day for 3 months, and rhinitis, sputum and bronchus depending on the degree of each person's feeling 9-point scoring method (9: almost complete cure, 7: good significant improvement, 5: some improvement, 3: insignificant improvement) for the improvement effect of function (cough frequency) No effect) was evaluated using, and the results are shown in Table 1 below.
(기침 빈도)(cough frequency)
상기 표 1에서 보는 바와 같이 본 발명 건강기능식품 실시예 1 내지 9의 경우, 비염, 가래 제거 및 기관지 기능(기침 빈도)에 상당한 개선 효과가 있음을 확인할 수 있다. 특히, 실시예 9의 경우, 기침 빈도의 측면에서 완치에 가까운 평가를 얻은 것으로 보아, 유효물질들 간의 시너지에 의한 개선효과가 매우 우수함을 확인할 수 있다.As shown in Table 1, in the case of Examples 1 to 9 of the health functional food of the present invention, it can be confirmed that there is a significant improvement effect on rhinitis, phlegm removal, and bronchial function (cough frequency). In particular, in the case of Example 9, it can be seen that the improvement effect due to the synergy between active substances is very excellent, considering that an evaluation close to a complete cure was obtained in terms of cough frequency.
따라서, 본 발명의 건강기능식품 내 포함된 유효물질들이 시너지 효과를 발휘하여 기침, 가래, 천식, 기관지염 등과 같이 환경오염과 불규칙한 생활 방식, 스트레스로 인한 각종 호흡기 질환의 위험에 노출되어 있는 현대인들에게 유용하게 이용될 수 있을 것으로 기대할 수 있다.Therefore, the active substances contained in the health functional food of the present invention exert a synergistic effect to modern people who are exposed to the risk of various respiratory diseases due to environmental pollution, irregular lifestyle, and stress such as cough, sputum, asthma, bronchitis, etc. It can be expected that it will be useful.
실험예 2. 면역증강 효능 평가Experimental Example 2. Immunity enhancement efficacy evaluation
실험을 위해 ICR mouse 50마리(6주령, 수컷, 23~28g)를 구입하고 1주일간 일반사료(Altromin, Germerny)를 자유식이하며 물을 충분히 공급해 주어 안정기를 보내도록 하였다. 7주령이 된 각 ICR mouse 복강에 면역억제제(Cyclophosphamide)를 150mg/kg 농도로 100㎕씩 실험 시작일과 시작 3일 후에 주사하여 면역 억제를 유도하였다. 실험은 총 14일 동안 진행되었으며, ICR mouse를 11그룹으로 나누어 하기 표 2에 기재된 바와 같이 각각의 조성물 등을 매일 1회, 오후 2시에 Oral zonde를 이용하여 200mg/kg의 용량으로 경구 투여하였다.For the experiment, 50 ICR mice (6 weeks old, male, 23-28g) were purchased, and regular feed (Altromin, Germerny) was freely fed for one week, and sufficient water was supplied to send a stable period. Immunosuppression was induced by injecting 100 μl of an immunosuppressant (cyclophosphamide) into the abdominal cavity of each 7-week-old ICR mouse at a concentration of 150 mg/kg on the start day and 3 days after the start of the experiment. The experiment was conducted for a total of 14 days, and ICR mice were divided into 11 groups, and each composition was orally administered at a dose of 200 mg/kg once a day at 2:00 pm using an Oral zonde as shown in Table 2 below. .
실험 종료 후, 심장 천자법을 이용하여 혈액을 채취하여 30분 간 상온에서 굳힌 후 3,000rpm에서 15분간 원심분리하여 분리한 혈청과 standard를 96well plate에 50㎕씩 분주하고 anti-mouse nulti-immunoglobulin beads를 각 25㎕씩 가하여 혼합한 후 15분 동안 실온에서 빛을 차단한 채 반응시키고 washing 완충 용액을 이용하여 2회 세척하였다. 그 후, 25㎕의 anti-mouse light chaim, PE를 가하여 15분 동안 실온에서 빛을 차단한 채 반응시키고 PBS를 150㎕ 넣고 5분간 혼합한 후 Luminex를 이용하여 면역글로불린을 측정하였다. 실험 결과는 SPSS 24.0의 independent two-sample t-test를 사용하여 통계처리 하였고, 그 결과를 하기 표 3에 나타내었다.After the experiment was completed, blood was collected using the cardiac puncture method, solidified at room temperature for 30 minutes, centrifuged at 3,000 rpm for 15 minutes, and the separated serum and standard were dispensed in 50 μl each in a 96-well plate and anti-mouse nulti-immunoglobulin beads 25 μl each was added and mixed, reacted at room temperature for 15 minutes while blocking light, and washed twice using a washing buffer solution. Thereafter, 25 μl of anti-mouse light chaim, PE was added and reacted at room temperature for 15 minutes while blocking light, and 150 μl of PBS was added, mixed for 5 minutes, and immunoglobulins were measured using Luminex. The experimental results were statistically processed using the independent two-sample t-test of SPSS 24.0, and the results are shown in Table 3 below.
(pg/ml)(pg/ml)
(pg/ml)(pg/ml)
(pg/ml)(pg/ml)
상기 표 3을 참고하면, 실시예 1 내지 9의 조성물이 투여된 그룹에서 면역세포의 유의성 있는 증가가 나타난 것을 확인할 수 있다. 특히, 실시예 9의 경우 가장 높은 증가가 나타난 것을 확인할 수 있다.Referring to Table 3, it can be confirmed that a significant increase in immune cells appeared in the groups to which the compositions of Examples 1 to 9 were administered. In particular, it can be confirmed that Example 9 showed the highest increase.
본 발명의 범위는 후술하는 청구범위에 의하여 나타내어지며, 청구범위의 의미 및 범위 그리고 그 균등 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다.The scope of the present invention is indicated by the following claims, and all changes or modifications derived from the meaning and scope of the claims and equivalent concepts should be interpreted as being included in the scope of the present invention.
Claims (5)
상기 모과는 전체 중량의 11 내지 13중량%, 감초는 10 내지 12 중량%, 대추는 9 내지 11 중량%, 도라지는 8 내지 10중량%, 맥문동 뿌리 8 내지 10 중량%, 오미자 열매 8 내지 10중량%, 더덕 6 내지 8중량%, 작두콩 6 내지 8중량%, 박하 잎 5 내지 7 중량%, 삼백초 5 내지 7 중량%, 생강 4 내지 6 중량%, 느릅나무 껍질 4 내지 6 중량% 및 영지버섯 3 내지 5 중량% 포함되는 것인,
기관지 기능의 개선 또는 면역기능의 증강을 위한 건강기능식품.
Contains extracts of quince, licorice, jujube, bellflower, rhubarb, schizandra, deodeok, soy bean, mint leaf, triticale, ginger, elm bark and ganoderma lucidum mixture,
11 to 13% by weight of the total weight of the quince, 10 to 12% by weight of licorice, 9 to 11% by weight of jujube, 8 to 10% by weight of bellflower, 8 to 10% by weight of quince root, 8 to 10% by weight of Schisandra fruit %, deodeok 6 to 8% by weight, soybean 6 to 8% by weight, mint leaves 5 to 7% by weight, Sambaekcho 5 to 7% by weight, ginger 4 to 6% by weight, elm bark 4 to 6% by weight, and Ganoderma lucidum 3 to 5% by weight,
Health functional food for improvement of bronchial function or enhancement of immune function.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220130190A KR102550993B1 (en) | 2022-10-12 | 2022-10-12 | Health functional food for improving bronchial function or enhancing immune function |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220130190A KR102550993B1 (en) | 2022-10-12 | 2022-10-12 | Health functional food for improving bronchial function or enhancing immune function |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102550993B1 true KR102550993B1 (en) | 2023-07-04 |
Family
ID=87156714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220130190A KR102550993B1 (en) | 2022-10-12 | 2022-10-12 | Health functional food for improving bronchial function or enhancing immune function |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102550993B1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170092733A (en) * | 2016-02-03 | 2017-08-14 | 김동명 | A composition of oriental medical herbs for prevention and/or improving of respiratory diseases |
KR20200139422A (en) * | 2019-06-04 | 2020-12-14 | 원광대학교산학협력단 | Composition for anti-rhinitis comprising sword bean extract as active component |
KR102300766B1 (en) * | 2020-12-11 | 2021-09-13 | 유송미 | Composition of health functional beverage for improving rhinitis, removing sputum and improving respiratory disease |
KR102368682B1 (en) | 2021-03-30 | 2022-03-02 | 이지현 | Producing method of mushroom crude drug compositon for enhencing immune system and composition produced by the method |
-
2022
- 2022-10-12 KR KR1020220130190A patent/KR102550993B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170092733A (en) * | 2016-02-03 | 2017-08-14 | 김동명 | A composition of oriental medical herbs for prevention and/or improving of respiratory diseases |
KR20200139422A (en) * | 2019-06-04 | 2020-12-14 | 원광대학교산학협력단 | Composition for anti-rhinitis comprising sword bean extract as active component |
KR102300766B1 (en) * | 2020-12-11 | 2021-09-13 | 유송미 | Composition of health functional beverage for improving rhinitis, removing sputum and improving respiratory disease |
KR102368682B1 (en) | 2021-03-30 | 2022-03-02 | 이지현 | Producing method of mushroom crude drug compositon for enhencing immune system and composition produced by the method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101279598B1 (en) | Composition for immune enhancement comprising the extract of Young antler, Cornus officinalis, Ligusticum acutilobum, Aurantii nobilis pericarpium, Chinese matrimony vine, lotus root, Yam, Curcuma aromatica Salisb, Gastrodia elata blume, Agastache rugosa, Cinnamomum loureirii, Ginseng steamed red and Schizandra chinensis, as active ingredient | |
KR100913243B1 (en) | A drink composition for eliminating hangover | |
KR100860080B1 (en) | Pharmaceutical composition comprising the plant extract belonged to Veronica genus having anti-inflammatory, anti-allergic and-asthmatic activity | |
KR102169920B1 (en) | A composition comprising extract of Schisandra chinensis, pear and Platycodon grandiflorum for preventing or treating respiratory inflammatory diseases | |
KR102252126B1 (en) | Composition for prevention or treatment respiratory diseases comprising combination extracts of Chrysanthemum morifolium Ramatuelle and Scutellaria baicalensis as an active ingredient | |
KR20110125295A (en) | Health assistance food used the euphorbia humifusa wild by main raw material and the manufacturing method therof | |
KR102371417B1 (en) | Composition for anti inflammation comprising extract of ginseng floral axis | |
EP4205558A1 (en) | Health functional food, comprising siberian chrysanthemum extract, for pain relief or antioxidation | |
KR102550993B1 (en) | Health functional food for improving bronchial function or enhancing immune function | |
KR20160071489A (en) | Composition for medicinal herbal tea and manufacturing method of composition for medicinal herbal by supercritical fluid extraction and manufacturing method of carbonated beverage and health beverage thereof | |
KR20200048459A (en) | Preparation manufacturing of composition for the improving of respiratory disease comprising pear and citron, and composition prepared thereby | |
KR20190001112A (en) | Anti-obesity composition comprising Protaetia brevitarsis seulensis larva extracts | |
KR20050100890A (en) | Composition comprising the extract of acanthopanax sessiliflorus and green tea for treating or alleviating hangover syndrome | |
KR20160128245A (en) | Composition for Preventing Alopecia and Improving Hair Growth Comprising the Extract of Anemarrhena Asphodeloides and Aralia Elata | |
KR20100116919A (en) | Compositions comprising extract from codonopsis lanceolata for preventing or treating obesity, hyperlipidemia or fatty liver | |
KR101894540B1 (en) | Composition for improving coenzyme Q10 with extract of Pinellia ternata, Atractylodes macrocephala, Gastrodia elata, Citrus unshiu peel, Poria cocos, Crataegus pinnatifida, Siegesbeckia pubescens Makino and Coptis japonica Makino | |
KR102421081B1 (en) | A composition for anti-smoke comprising niacin | |
CN104940428B (en) | Hypoglycemic composition containing wolfberry fruits and application thereof | |
KR102355106B1 (en) | Pharmaceutical and functional food composition comprising complex extract of Platycodon grandiflorus for prevention or treatment of respiratory disease | |
KR102639283B1 (en) | A Composition For Preventing, Improving Or Treating Gastrointestinal Disorders Including Dry Ginger Extract And Pomegranate Extract | |
KR102355104B1 (en) | Pharmaceutical and functional food composition comprising complex extract of Brassica rapa for prevention or treatment of respiratory disease | |
KR102452138B1 (en) | Ginseng processed food composition comprising composition for shielding bitter taste | |
KR102402571B1 (en) | Method for Making Chewable Tablet Containing Red Ginseng | |
KR102415268B1 (en) | Composition Comprising the Extract of Acanthopanax koreanum for the Prevention or Treatment of Nicotine Addiction and Withdrawl Symptoms | |
KR20220157170A (en) | A Composition For Preventing, Improving Or Treating Gastrointestinal Disorders Including Eucommia ulmoides Oliver Extract And Red Ginseng Extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GRNT | Written decision to grant |